Structure-guided TLR7 reporter response and validation controls
Cell-based study · Huh7 cells expressing wild-type or mutant human TLR7 with an NF-κB luciferase reporter; empty-vector control. [1]
GS-9620 activated the wild-type TLR7 reporter. Y356S, F408A, D555A, L557D and L557Y/T586G variants had strongly reduced GS-9620 responses. The L557 variants retained more resiquimod responsiveness, whereas Y356S, F408A and D555A impaired both agonists. Control substitutions outside the proposed pocket retained activity.
| Endpoint | Reported result | Reference |
|---|---|---|
| GS-9620-induced NF-κB reporter response in Y356S, F408A, D555A, L557D and L557Y/T586G TLR7 variants versus wild-type TLR7 | Reporter AUC reduction 4-fold or greater reduction | [1] |
| Resiquimod response and reporter/expression controls | Comparative response Y356S, F408A and D555A also showed 4-fold or greater AUC reduction with resiquimod; IL-1β reporter responses and TLR7 protein expression were retained across tested constructs. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- GS-9620: four-point two-fold titration starting at 5 μM; resiquimod: starting at 10 μM.
- Exposure duration
- Compounds added 24 h after transfection; luciferase measured after 20 h stimulation.
- Method
- Cell-based NF-κB luciferase reporter assay.
- Vehicle
- DMSO vehicle and normalization control; final percentage not specified in the cited reporter methods.
- Co-treatment
- Agonists tested separately; IL-1β used as a separate signaling control.
- Reported limits
- No binding affinity or receptor-occupancy measurement; no EC50 fitted for this study. Salt state and analytical purity not established in selected sections.
Methods and source locations
Compound reported in the paper: GS-9620; Compound label in the paper: GS-9620; resiquimod comparator
Evidence concerns the authors’ GS-9620 material; it does not validate an Adooq lot or establish equivalence of formulations.
Fig 2b–c and caption; Results: structure-guided mutational analysis; NF-κB reporter assay methods; S4a–c and caption
GS-9620-induced NF-κB reporter response in Y356S, F408A, D555A, L557D and L557Y/T586G TLR7 variants versus wild-type TLR7: Luciferase normalized to DMSO; four-point two-fold compound titration. Caption reports mean and SEM of triplicate assay conditions; representative of three independent experiments. — Fig 2b–c and caption; Results: structure-guided mutational analysis; NF-κB reporter assay methods; S4a–c and caption
Resiquimod response and reporter/expression controls: Resiquimod reporter comparator; IL-1β bypass control in S4b; anti-TLR7 immunoblot with GAPDH control in S4c. No densitometric equality is inferred. — Fig 2b–c and caption; Results: structure-guided mutational analysis; NF-κB reporter assay methods; S4a–c and caption